• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不稳定型心绞痛的危险分层。Braunwald分类法的前瞻性验证。

Risk stratification in unstable angina. Prospective validation of the Braunwald classification.

作者信息

Calvin J E, Klein L W, VandenBerg B J, Meyer P, Condon J V, Snell R J, Ramirez-Morgen L M, Parrillo J E

机构信息

Section of Cardiology, Rush-Presbyterian-St Luke's Medical Center, Chicago, Ill. 60612.

出版信息

JAMA. 1995 Jan 11;273(2):136-41.

PMID:7799494
Abstract

OBJECTIVES

To validate the Braunwald classification of unstable angina as a predictor of in-hospital cardiac complications; to determine which factors of the Braunwald classification contributed significantly to this prediction; and to devise a method of combining these predictive factors into an overall odds ratio for complications.

DESIGN

A validation cohort of consecutive patients followed prospectively for in-hospital cardiac complications including myocardial infarction and death.

SETTING

A community-based academic medical center.

PATIENTS

A total of 393 patients admitted consecutively to the coronary care and intermediate care units with unstable angina.

MAIN OUTCOME MEASURES

Major cardiac complications including death, myocardial infarction, congestive heart failure, cardiogenic shock, and severe ventricular dysrhythmias.

RESULTS

Multiple logistic regression analysis identified four clinical factors used in the Braunwald classification that predicted the in-hospital occurrence of major cardiac complications: (1) myocardial infarction within less than 14 days (odds ratio [OR], 5.72; 95% confidence interval [CI], 1.92 to 16.97); (2) need for intravenous nitroglycerin (OR, 2.33; 95% CI, 1.31 to 4.17); (3) lack of beta-blocker or calcium channel blocker prior to admission (OR, 3.83; 95% CI, 1.55 to 9.42); and (4) baseline ST depression (OR, 2.81; 95% CI, 1.45 to 5.47). Two other clinical factors, diabetes and age, were also significant predictors. Validation of this model using parametric and nonparametric bootstrap techniques revealed excellent agreement between the CIs for adjusted ORs derived from the multiple logistic regression and those derived from the bootstrap.

CONCLUSIONS

The classification of unstable angina proposed by Braunwald includes four factors that predict risk of major in-hospital cardiac complications. Specific factors used in this classification can be combined with diabetes and age to better stratify risk of major cardiac complications in this disorder using a simpler model.

摘要

目的

验证不稳定型心绞痛的Braunwald分类法作为住院心脏并发症预测指标的有效性;确定Braunwald分类法中的哪些因素对该预测有显著贡献;并设计一种方法将这些预测因素组合成并发症的总体比值比。

设计

对连续患者组成的验证队列进行前瞻性随访,观察住院心脏并发症,包括心肌梗死和死亡。

地点

一个基于社区的学术医疗中心。

患者

共有393例因不稳定型心绞痛连续入住冠心病监护病房和中级护理病房的患者。

主要观察指标

主要心脏并发症,包括死亡、心肌梗死、充血性心力衰竭、心源性休克和严重室性心律失常。

结果

多因素logistic回归分析确定了Braunwald分类法中用于预测住院期间主要心脏并发症发生的四个临床因素:(1)14天内发生心肌梗死(比值比[OR],5.72;95%置信区间[CI],1.92至16.97);(2)需要静脉使用硝酸甘油(OR,2.33;95%CI,1.31至4.17);(3)入院前未使用β受体阻滞剂或钙通道阻滞剂(OR,3.83;95%CI,1.55至9.42);(4)基线ST段压低(OR,2.81;95%CI,1.45至5.47)。另外两个临床因素,糖尿病和年龄,也是显著的预测因素。使用参数和非参数自抽样技术对该模型进行验证,结果显示多因素logistic回归得出的校正OR的CI与自抽样得出的CI之间具有良好的一致性。

结论

Braunwald提出的不稳定型心绞痛分类法包含四个预测住院期间主要心脏并发症风险的因素。该分类法中使用的特定因素可与糖尿病和年龄相结合,以使用更简单的模型更好地分层该疾病中主要心脏并发症的风险。

相似文献

1
Risk stratification in unstable angina. Prospective validation of the Braunwald classification.不稳定型心绞痛的危险分层。Braunwald分类法的前瞻性验证。
JAMA. 1995 Jan 11;273(2):136-41.
2
Incidence and follow-up of Braunwald subgroups in unstable angina pectoris.不稳定型心绞痛中Braunwald亚组的发病率及随访情况。
J Am Coll Cardiol. 1995 May;25(6):1286-92. doi: 10.1016/0735-1097(95)00009-S.
3
Predictive validity of the Braunwald classification of unstable angina for angiographic findings, short-term prognoses, and treatment selection.
Angiology. 1997 Aug;48(8):663-71. doi: 10.1177/000331979704800801.
4
Supplemental value of troponin I combined with a clinical risk model to predict in-hospital events in intermediate and high risk patients with acute coronary syndromes.肌钙蛋白I联合临床风险模型对中高危急性冠脉综合征患者院内事件的预测价值
J Invasive Cardiol. 2002 Oct;14(10):603-8.
5
Management of patients with unstable angina in a general cardiology unit.综合心脏病科病房不稳定型心绞痛患者的管理
N Z Med J. 1998 Aug 14;111(1071):288-91.
6
Validation of the Agency for Health Care Policy and Research (AHCPR) classification for managing unstable angina.医疗保健政策与研究机构(AHCPR)对不稳定型心绞痛管理分类的验证。
J Clin Epidemiol. 1999 Oct;52(10):959-65. doi: 10.1016/s0895-4356(99)00117-1.
7
Clinical predictors of 30-day cardiac events in patients with acute coronary syndrome at a community hospital.社区医院急性冠状动脉综合征患者30天心脏事件的临床预测因素
South Med J. 2003 Nov;96(11):1113-20. doi: 10.1097/01.SMJ.0000053481.49309.58.
8
Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3. The ECLA Collaborative Group.不稳定型心绞痛住院预后的临床预测因素:ECLA 3。ECLA协作组
Am Heart J. 1999 Feb;137(2):322-31. doi: 10.1053/hj.1999.v137.93029.
9
Early and late mortality after surgery for unstable angina in relation to Braunwald class.不稳定型心绞痛手术后的早期和晚期死亡率与Braunwald分级的关系
Am Heart J. 2001 Jan;141(1):9-14. doi: 10.1067/mhj.2001.111955.
10
[Effects of preceding stable or unstable angina on hospital morbidity-mortality of myocardial infarction. Results of a continuous series of 1,910 patients].
Arch Mal Coeur Vaiss. 2002 Feb;95(2):87-92.

引用本文的文献

1
Risk stratification and in-hospital outcome in patients with acute coronary syndrome.急性冠状动脉综合征患者的风险分层与院内结局
J Family Med Prim Care. 2022 Jun;11(6):2780-2788. doi: 10.4103/jfmpc.jfmpc_1805_21. Epub 2022 Jun 30.
2
Risk Stratification of Patients with Acute Coronary Syndrome.急性冠状动脉综合征患者的风险分层
J Clin Med. 2021 Oct 1;10(19):4574. doi: 10.3390/jcm10194574.
3
Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study.
铁代谢与冠状动脉疾病的预后相关:AtheroGene 研究中可溶性转铁蛋白受体的预后价值。
J Am Heart Assoc. 2020 May 5;9(9):e015480. doi: 10.1161/JAHA.119.015480. Epub 2020 Apr 23.
4
Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.心血管-肾脏生物标志物可溶性尿激酶型纤溶酶原激活物受体与冠心病患者心血管死亡和心肌梗死相关,与肌钙蛋白、C 反应蛋白和肾功能无关。
J Am Heart Assoc. 2020 Apr 21;9(8):e015452. doi: 10.1161/JAHA.119.015452. Epub 2020 Apr 17.
5
Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease.三种已确立的风险标志物(高敏肌钙蛋白 I、C 反应蛋白和 NT-proBNP)在冠状动脉疾病中的增量预测价值的头对头比较。
Biomolecules. 2020 Mar 4;10(3):394. doi: 10.3390/biom10030394.
6
Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease-First Report on the Prospective Relevance of Intrinsic Iron Release.固有铁释放与稳定型冠状动脉疾病患者的死亡率降低相关——固有铁释放的前瞻性相关性的首次报告。
Biomolecules. 2018 Aug 9;8(3):72. doi: 10.3390/biom8030072.
7
Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome.急性冠状动脉综合征患者缺铁不良结局预测。
Biomolecules. 2018 Jul 20;8(3):60. doi: 10.3390/biom8030060.
8
Prognostic Value of Iron-Homeostasis Regulating Peptide Hepcidin in Coronary Heart Disease-Evidence from the Large AtheroGene Study.铁稳态调节肽hepcidin 在冠心病中的预后价值——来自大atherogene 研究的证据。
Biomolecules. 2018 Jun 28;8(3):43. doi: 10.3390/biom8030043.
9
Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome.糖尿病合并急性冠状动脉综合征患者的血运重建策略
Curr Cardiol Rep. 2016 Aug;18(8):79. doi: 10.1007/s11886-016-0756-3.
10
Prospective validation of the Dante Pazzanese risk score in non-ST-segment elevation acute coronary syndrome.前瞻性验证 Dante Pazzanese 风险评分在非 ST 段抬高型急性冠状动脉综合征中的应用。
Arq Bras Cardiol. 2013 Sep;101(3):197-204. doi: 10.5935/abc.20130163. Epub 2013 Aug 14.